Cancer care

Pharmaceutical firms cut price of cancer drugs for African countries

Two major pharmaceutical companies are to cut the price of cancer drugs to sub-Saharan African countries following a brokered by the American Cancer Society (ACS) and the Clinton Health Access Initiative (CHAI).

The agreement with US pharmaceutical giant Pfizer and Indian pharmaceutical company Cipla will set ‘competitive prices’ for 16 cancer treatment medications, including chemotherapies, for health providers in Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania.

The initiative is modelled on the campaign to improve access to HIV medicines in Africa, and it will be supported by IBM Health Corps, who will provide free chemotherapy forecasting software to help countries quantify their cancer medicine needs and plan budgets and procurement.

An estimated 44% of all cancer cases in sub-Saharan Africa each year occur in the six targeted countries, and this agreement is part of a wider effort by ACS and supported by CHAI to improve the market environment for cancer care in Africa.

Gary M Reedy, chief executive of the ACS, said: “Every person with cancer deserves access to treatment, no matter where they live. Collaborating with companies like Pfizer and Cipla is a critical next step toward levelling the playing field for people with cancer and saving lives in this part of the world.”

In 2012, there were an estimated 626,000 new cases of cancer and 447,000 cancer deaths in sub-Saharan Africa, a figure which is set to double by 2030 because of ageing populations.

But the ACS says global funding for cancer prevention and treatment in lower-income countries is far lower than for other diseases including HIV, malaria and tuberculosis.

Trudi Hilton, a pharmacist consultant in resource-limited settings, welcomed the initiative, but warned that cost was not the only limiting factor in improving access to medicines.

“Access to medicines has a lot to do with health literacy — patients being aware of symptoms and how to report them in a timely manner so that they can access appropriate healthcare,” she said.

“Pharmacists are essential health educators as they may be the first port of call in community settings but only if they actively engage local populations and are not seen as purely profiting from ill-health through sales of medicines.”

Citation: The Salvadore DOI: 10.1211/PJ.2017.20203722

Readers' comments (1)

  • Michael Achiampong

    I am heartened to read of this development for African populations. I also agree with the necessity to improve the health literacy and that locally based healthcare practitioners can facilitate this. Now, how about other pharma/biotech/start-ups in non-communicable and communicable diseases following suit in making their medicines and devices etc more affordable? And therefore more accessible to other low-to-middle income populations?

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmacy Registration Assessment Questions 2

    Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.

    £35.00
  • Pharmacy Registration Assessment Questions

    Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.

    £33.00
  • Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 (The Orange Guide)

    Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.

    £82.00
  • Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00
  • Clinical Pharmacy Pocket Companion

    An A-Z pocket book containing concise and practical pharmaceutical information for busy clinical pharmacists.

    £33.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Supplementary images

  • Pills in hand ss 17

Jobs you might like

  • London Bridge/Work from Home

  • Nottingham, Nottinghamshire

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

У нашей фирмы интересный интернет-сайт с информацией про Кленодин Кленодин
www.cialis-viagra.com.ua/dapoksetin-prodlenie-akta/